Glanbia PLC
F:GL9

Watchlist Manager
Glanbia PLC Logo
Glanbia PLC
F:GL9
Watchlist
Price: 15.42 EUR 1.65% Market Closed
Market Cap: €4.1B

Glanbia PLC
Investor Relations

Glanbia PLC, with roots firmly embedded in the Emerald Isle, is a testament to the evolution and innovation in the global food industry. Originally emerging from the dairy cooperatives of Ireland, Glanbia has masterfully transformed itself from a local dairy operation into a global nutritional powerhouse. At the heart of its operations is a deep-seated commitment to nutrition – crafting products that cater to the growing global demand for healthier, functional foods. The company's business model is intricately woven around two core divisions: Glanbia Performance Nutrition, which crafts and supplies a diverse portfolio of performance nutrition products, and Glanbia Nutritionals, which delivers bespoke nutritional solutions through its comprehensive dairy and non-dairy ingredients. These synergistic divisions allow Glanbia to tap into and steer multiple nodes of the health and wellness megatrend.

The financial heartbeat of Glanbia comes from its ability to marry science with nutritional innovation. By leveraging advanced research and development capabilities, the company consistently innovates, ensuring its offerings remain at the cutting edge of consumer trends. Glanbia Performance Nutrition's leading brands like Optimum Nutrition and SlimFast cater to fitness enthusiasts and health-conscious consumers, translating into robust sales globally. Meanwhile, Glanbia Nutritionals' sophisticated ingredients and solutions, utilized by leading brands in the food and beverage industry, underpin a reliable revenue stream. This dual-engine strategy ensures Glanbia not only meets current market demands but is also strategically positioned to adapt to the fluid dynamics of the health-focused consumer marketplace. Through this, Glanbia PLC fortifies its standing as not just a company, but a vital participant in the global narrative of nutritional well-being.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 5, 2025
AI Summary
Q3 2025

Revenue Growth: Group revenue rose 3.3% year-to-date, ahead of expectations, with strong performances in all segments.

Upgraded Guidance: Performance Nutrition like-for-like revenue growth guidance was raised to 3%–4%, and full-year adjusted EPS is now expected at the upper end of the $1.30–$1.33 range.

Brand Strength: Optimum Nutrition and Isopure saw double-digit volume growth in Q3, helped by innovation, increased distribution, and strong consumer demand.

Whey Cost Pressures: Whey prices remain elevated and are expected to be inflationary into 2026, leading to further pricing actions, especially in North America.

Transformation and Portfolio: Completed the sale of non-core brands SlimFast and Body & Fit; acquired Sweetmix in Brazil to strengthen Health & Nutrition.

Cash Returns: Over 15 million shares repurchased YTD at a cost of EUR 197 million; dividends totaling EUR 103 million returned to shareholders.

Key Financials
Group Revenue Growth
3.3%
Performance Nutrition like-for-like Revenue Growth (YTD, excl. SlimFast & Body & Fit)
2.5%
Health & Nutrition like-for-like Revenue Growth (YTD)
6.1%
Dairy Nutrition like-for-like Revenue Growth (YTD)
6.1%
Optimum Nutrition like-for-like Revenue Growth
4.6%
Optimum Nutrition U.S. Consumption Growth
8.8%
Isopure U.S. Consumption Growth
6.8%
Performance Nutrition International like-for-like Revenue Growth (YTD, excl. SlimFast & Body & Fit)
8.8%
Health & Nutrition Volume Growth (YTD)
6.9%
Health & Nutrition Price Change (YTD)
-0.8%
Dairy Nutrition Volume Growth (YTD)
3.5%
Dairy Nutrition Price Growth (YTD)
2.6%
Net Debt (End Q3)
$719 million
Capital Expenditure (2025 expected)
$80 million–$90 million
Share Repurchases (YTD)
EUR 197 million (over 15 million shares at EUR 13.10 avg)
Dividend Returned to Shareholders (YTD)
EUR 103 million
Adjusted Earnings per Share Guidance (2025)
$1.30–$1.33
Performance Nutrition EBITDA Margin Guidance (2025)
13%–14%
Health & Nutrition EBITDA Margin Guidance (2025)
18%–19%
Operating Cash Flow Conversion Guidance (2025)
over 80%
Other Earnings Calls
2025
2023
2022

Management

Mr. Mark A. Garvey
CFO & Executive Director
No Bio Available
Mr. Hugh McGuire Dip Finance, M.Sc
CEO & Executive Director
No Bio Available
Mr. Liam Hennigan
Group Secretary & Head of Investor Relations
No Bio Available
Ms. Martha Kavanagh
Head of Corporate Communications
No Bio Available
Mr. Ian Doyle
Chief Corporate Development Officer
No Bio Available
Ms. Sue Sweem
Chief Human Resources Officer
No Bio Available
Mr. Michael Patten
Chief ESG & Corporate Affairs Officer
No Bio Available
Mr. Tom Tench
Chief Operating Officer of Glanbia Nutritionals
No Bio Available
Mr. Brian Phelan B. Comm, FCA
Chief Executive Officer of Glanbia Nutritionals
No Bio Available
Mr. Jim Bergin B. Comm
Chief Executive of Glanbia Ingredients Ireland Limited
No Bio Available

Contacts

Address
KILKENNY
KILKENNY
Glanbia House, Ring Road
Contacts
+353567772200.0
www.glanbia.com